Table 3.
Prevalence of Metabolic dysfunction.
| Initial Visit | Last Visit | Interval Change | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | BMI- NR |
BMI- R |
p R-NR |
Total | BMI-NR | BMI- R |
p R-NR |
p Total | Mean ∆, BMI-NR |
Mean ∆, BMI-R |
p R-NR |
|
| HbA1c | 5.27 (0.38) |
5.25 (0.33) | 5.29 (0.44) | 0.51 | 5.25 (0.35) | 5.23 (0.32) | 5.28 (0.39) | 0.38 | 0.98 | –0.01 (0.19) |
–0.01 (0.22) |
0.824 |
| Glucose, mg/dL | 87.10 (6.47) | 87.14 (6.46) | 87.04 (6.54) | 0.92 | 88.07 (6.22) | 88.91 (6.11) | 86.95 (46.26) | 0.07 | 0.33 | 1.76 (6.31) |
–0.09 (2.39) |
0.021 |
| ALT, U/L |
30.76 (27.69) |
30.00 (30.91) |
31.75 (22.95) |
0.68 | 26.36 (18.09) |
26.73 (20.23) |
25.87 (14.93) |
0.76 | 0.14 | –3.27 (17.44) |
–5.88 (16.39) |
0.338 |
| Triglycerides, mg/dL | 121.86 (65.90) |
120.50 (60.65) |
123.67 (72.74) | 0.76 | 116.52 (70.55) |
127.47 (82.77) |
101.91 (46.54) |
0.01 | 0.001 | 6.97 (57.14) |
–21.75 (53.11) |
0.001 |
| Total Chol, mg/dL | 158.81 (29.03) | 154.27 (30.09) |
164.87 (26.57) | 0.02 | 154.91 (26.98) |
153.30 (28.22) |
157.04 (25.29) |
0.38 | 0.008 | –0.97 (15.52) |
–7.83 (20.87) |
0.023 |
| LDL-c, mg/dL |
89.71 (24.88) |
86.38 (26.44) |
94.14 (22.05) |
0.05 | 86.99 (22.85) |
84.42 (23.67) |
90.41 (21.40) |
0.10 | 0.28 | –1.96 (15.65) |
–3.74 (17.11) |
0.493 |
| HDL-c, mg/dL | 44.84 (8.56) |
43.51 (8.75) |
46.62 (8.03) | 0.02 | 44.53 (9.01) |
43.32 (9.46) |
46.16 (8.14) |
0.04 | 0.64 | –0.20 (5.09) |
–0.46 (4.56) |
0.730 |
Data are presented as mean (SD). ALT = alanine aminotransferase, BMI = body mass index, Total Chol = total cholesterol, HbA1c = glycated hemoglobin, HDL-c = high-density lipoprotein cholesterol, LDL-c = low-density lipoprotein cholesterol, NR = non-responders, R = responders. ∆ = delta.